Thomas Strungmann
4Patents
2h-index
6Co-inventors
41Inventor score
Filing activity: Jun 22, 2001 → Feb 26, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6579536B1 | Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient | Human Necessities | 46 | Expired |
| US10925927B2 | Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist | Chemistry; Metallurgy | 5 | Active |
| US11666632B2 | Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist | Chemistry; Metallurgy | 2 | Active |
| US11298405B2 | Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.